Clinical Trial Update: RO4929097 in Treating Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of RO4929097 in metastatic colorectal cancer (recurrent colon or rectal cancer, including Stage IV) completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• RO4929097 (RO4929097)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-06-11